| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Depression > Let's Analyze the Prescribed Medicines for Treating Depression |
|
E-Articles - Let's Analyze the Prescribed Medicines for Treating Depression
Considering the high percentage of depressed Americans (about 10 % of the population to be exact) According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product , it should come as no surprise that some form of prescribed medicines for treating depression is ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in being administered to depressed patients on an almost daily basis. However, based on studies and lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. some documented instances, what should be more of a concern are the side-effects common to these here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe forms of medications supposedly made for dealing with depression. Let’s go over some of the comm d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro n ones: Prozac: Although this depression medication may adjust the levels of serotonin ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc n the brain (the chemical linked to happiness), this drug has been proven to have unpleasant ment easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi al and physical side effects. Furthermore, any improvement in a depression condition remains only nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically as long as the drug is used. Zoloft: According to the drug’s own official website, the and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ost common side effects to this depression medication are episodes of having any of the following ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi -Dry mouth -Upset stomach -Decreased appetite -Fatigue -Trouble sleeping -Sexual dysfuncti ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a on -Diarrhea, tremor The natural tendency of most patients upon being informed of these dangers dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod is to cease the use of these drugs, however, reports do show that it may not be as easy as it app cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ars to do such. Withdrawal symptoms to these drugs supposedly have included dizziness, extreme n tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ausea and high fever. So, where does this leave a patient seeking help? I would say it will be t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel f uttermost importance at this stage to educate one’s self on as many options of dealing with dep ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ession as possible to be able to cope with the problem. It perhaps may work best with a combinat y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ion of techniques or approaches-as some experts suggest-but the most important factor is to remem . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de er to be as sure as possible on what combination or exclusive approach you would like to take to elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip andle the signs of depression you may be going through…signs which can be handled To Health, Aj tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Consolidate Your Multiple Debts with Unsecured Personal Loan Copyright infringement - What's New To Handle Stealing?
|